Ieq Capital LLC Sells 1,806 Shares of Doximity, Inc. (NASDAQ:DOCS)

Ieq Capital LLC cut its position in Doximity, Inc. (NASDAQ:DOCS) by 1.8% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 97,333 shares of the company’s stock after selling 1,806 shares during the quarter. Ieq Capital LLC’s holdings in Doximity were worth $2,722,000 as of its most recent SEC filing.

A number of other hedge funds have also added to or reduced their stakes in DOCS. William Blair Investment Management LLC lifted its stake in shares of Doximity by 15.8% in the 2nd quarter. William Blair Investment Management LLC now owns 6,404,068 shares of the company’s stock valued at $179,122,000 after acquiring an additional 873,682 shares during the last quarter. Swedbank AB bought a new position in shares of Doximity in the first quarter valued at approximately $91,673,000. Janus Henderson Group PLC increased its holdings in Doximity by 33.5% during the first quarter. Janus Henderson Group PLC now owns 2,474,695 shares of the company’s stock worth $66,594,000 after buying an additional 621,590 shares during the last quarter. Edmond DE Rothschild Holding S.A. raised its holdings in shares of Doximity by 15.1% in the 4th quarter. Edmond DE Rothschild Holding S.A. now owns 2,302,240 shares of the company’s stock worth $64,555,000 after purchasing an additional 301,290 shares during the period. Finally, Capital World Investors lifted its position in shares of Doximity by 250.7% during the 1st quarter. Capital World Investors now owns 1,714,707 shares of the company’s stock valued at $46,143,000 after buying an additional 1,225,707 shares during the last quarter. 87.19% of the stock is owned by institutional investors.

Insider Transactions at Doximity

In other Doximity news, Director Watkin Phoebe L. Yang sold 1,011 shares of the firm’s stock in a transaction on Monday, August 5th. The stock was sold at an average price of $25.54, for a total value of $25,820.94. Following the transaction, the director now owns 11,258 shares in the company, valued at approximately $287,529.32. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In other news, Director Watkin Phoebe L. Yang sold 1,011 shares of the company’s stock in a transaction on Monday, August 5th. The stock was sold at an average price of $25.54, for a total value of $25,820.94. Following the transaction, the director now owns 11,258 shares of the company’s stock, valued at approximately $287,529.32. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Watkin Phoebe L. Yang sold 1,940 shares of Doximity stock in a transaction that occurred on Monday, July 29th. The shares were sold at an average price of $28.22, for a total transaction of $54,746.80. Following the completion of the sale, the director now owns 12,269 shares of the company’s stock, valued at approximately $346,231.18. The disclosure for this sale can be found here. Insiders sold a total of 37,951 shares of company stock valued at $1,271,018 in the last three months. 39.40% of the stock is currently owned by company insiders.

Doximity Trading Up 0.6 %

DOCS opened at $40.88 on Friday. Doximity, Inc. has a 12 month low of $19.71 and a 12 month high of $41.05. The stock has a fifty day moving average price of $33.47 and a 200-day moving average price of $29.08. The firm has a market cap of $7.58 billion, a price-to-earnings ratio of 56.78, a PEG ratio of 5.15 and a beta of 1.27.

Doximity (NASDAQ:DOCS) last released its earnings results on Thursday, August 8th. The company reported $0.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.16 by $0.06. Doximity had a return on equity of 19.26% and a net margin of 32.53%. The firm had revenue of $126.68 million for the quarter, compared to the consensus estimate of $119.88 million. On average, equities research analysts forecast that Doximity, Inc. will post 0.8 EPS for the current year.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on the company. Bank of America lifted their price target on Doximity from $29.00 to $32.00 and gave the company a “neutral” rating in a research report on Friday, August 9th. JPMorgan Chase & Co. lifted their price target on shares of Doximity from $27.00 to $30.00 and gave the stock a “neutral” rating in a research note on Monday, August 19th. Baird R W raised Doximity to a “strong-buy” rating in a research note on Tuesday, September 17th. Wells Fargo & Company cut shares of Doximity from an “equal weight” rating to an “underweight” rating and dropped their price target for the company from $27.00 to $19.00 in a research report on Thursday, July 18th. Finally, Needham & Company LLC raised Doximity from a “hold” rating to a “buy” rating and set a $38.00 target price on the stock in a research note on Friday, August 9th. Two equities research analysts have rated the stock with a sell rating, eight have issued a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $32.42.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.